| Business Type | Exporter, Supplier, Retailer |
| Weight | 50 MG |
| Type | Targeted anticancer therapy |
| Brand Name | OLANIB |
| Click to view more | |
Product Details
Material
Olaparib with approved pharmaceutical excipients
Color
Film-coated tablets
Size
1120
Country of Origin
USA
Port
California
Payment Terms
T/T, Western Union, Other
Delivery Time
3 days
Packaging Details
Packaging Type: Blister packs or HDPE bottles
Packaging Size: Typically 30 tablets, 60 tablets, or as per manufacturer
Label Information: Brand name, strength, batch number, manufacturing date, expiry date
Outer Carton: Included with patient information leaflet
Storage Conditions
Store below 25°C
Protect from moisture and light
Keep in original packaging until use
Packaging Size: Typically 30 tablets, 60 tablets, or as per manufacturer
Label Information: Brand name, strength, batch number, manufacturing date, expiry date
Outer Carton: Included with patient information leaflet
Storage Conditions
Store below 25°C
Protect from moisture and light
Keep in original packaging until use
OLANIB (Olaparib) Tablets
OLANIB is a prescription anticancer medication containing olaparib, a PARP (poly ADP-ribose polymerase) inhibitor used in the treatment of certain cancers with specific genetic characteristics. It is taken orally and used under the supervision of an oncologist.
Therapeutic Uses / Indications
OLANIB is indicated for the treatment of:
-
Ovarian cancer (BRCA-mutated, advanced or recurrent)
-
Breast cancer (HER2-negative, BRCA-mutated)
-
Pancreatic cancer (with BRCA mutation)
-
Prostate cancer (metastatic, castration-resistant, with homologous recombination repair gene mutations)
peptidevera@
Looking for "Olanib Olaparib Tablets" ?
Box
